Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 17 studies | 43% ± 16% | |
| endothelial cell | 11 studies | 21% ± 7% | |
| endothelial cell of lymphatic vessel | 9 studies | 21% ± 5% | |
| deuterosomal cell | 4 studies | 23% ± 4% | |
| epithelial cell | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of TNFAIP8L1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1160.52 | 1444 / 1445 | 100% | 12.60 | 183 / 183 |
| intestine | 100% | 3185.11 | 966 / 966 | 100% | 10.51 | 526 / 527 |
| liver | 100% | 2467.81 | 226 / 226 | 100% | 18.94 | 405 / 406 |
| uterus | 100% | 862.81 | 170 / 170 | 99% | 13.43 | 454 / 459 |
| skin | 100% | 786.02 | 1801 / 1809 | 99% | 8.39 | 467 / 472 |
| breast | 100% | 861.50 | 457 / 459 | 99% | 10.29 | 1106 / 1118 |
| lung | 99% | 1261.54 | 575 / 578 | 99% | 9.90 | 1142 / 1155 |
| bladder | 100% | 1031.86 | 21 / 21 | 98% | 9.62 | 495 / 504 |
| ovary | 98% | 593.84 | 176 / 180 | 99% | 8.91 | 425 / 430 |
| kidney | 100% | 1112.08 | 89 / 89 | 93% | 12.19 | 841 / 901 |
| stomach | 94% | 1473.39 | 337 / 359 | 99% | 11.28 | 283 / 286 |
| thymus | 99% | 893.24 | 649 / 653 | 92% | 5.58 | 556 / 605 |
| brain | 90% | 851.82 | 2380 / 2642 | 96% | 6.55 | 676 / 705 |
| adrenal gland | 93% | 444.13 | 240 / 258 | 72% | 4.34 | 166 / 230 |
| prostate | 95% | 551.07 | 233 / 245 | 59% | 1.99 | 294 / 502 |
| pancreas | 50% | 167.99 | 165 / 328 | 98% | 9.22 | 175 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.23 | 29 / 29 |
| spleen | 100% | 2491.09 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.66 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.81 | 1 / 1 |
| adipose | 99% | 971.38 | 1194 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 4.33 | 73 / 80 |
| heart | 89% | 498.57 | 763 / 861 | 0% | 0 | 0 / 0 |
| muscle | 72% | 265.62 | 581 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 62% | 566.84 | 572 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 61% | 288.89 | 821 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032007 | Biological process | negative regulation of TOR signaling |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TNFAIP8L1 |
| Protein name | Tumor necrosis factor alpha-induced protein 8-like protein 1 (TIPE1) (TNF alpha-induced protein 8-like protein 1) (TNFAIP8-like protein 1) (Oxidative stress-regulated gene-beta) (Oxy-beta) |
| Synonyms | |
| Description | FUNCTION: Acts as a negative regulator of mTOR activity. . |
| Accessions | ENST00000327473.9 ENST00000536716.1 Q8WVP5 |